RebeccaArendMD
Obstetrics & Gynecology • Birmingham, ALGynecologic Oncology
Academic Appointment: Associate Professor - UAB Women & Infants Center
Dr. Arend is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
619 19th St S
Birmingham, AL 35249Phone+1 205-205-4011Fax+1 205-934-7779- Is this information wrong?
Summary
- Dr. Rebecca Arend is an obstetrician/gynecologist in Birmingham, AL and is affiliated with UAB Hospital. She received her medical degree from Albert Einstein College of Medicine and has been in practice 9 years. She specializes in gynecologic oncology and is experienced in gynecologic oncology.
Education & Training
University of Alabama Medical CenterFellowship, Gynecologic Oncology, 2015
New York Presbyterian Hospital (Columbia Campus)Residency, Obstetrics and Gynecology, 2008 - 2012
Albert Einstein College of MedicineClass of 2008
Certifications & Licensure
AL State Medical License 2012 - 2024
NY State Medical License 2011 - 2012- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Low Grade Endometrial Cancer Start of enrollment: 2017 Nov 15
- A Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial or Epithelial Ovarian Cancer or Carcinosarcoma Start of enrollment: 2018 Mar 05
- Trial of M4344 and Niraparib in Patients With Poly (ADP-ribose) Polymerase (PARP) Resistant Recurrent Ovarian Cancer Start of enrollment: 2023 May 01
- Join now to see all
Publications & Presentations
PubMed
- Dedicated financial hardship screening adds value to routine distress screening among gynecologic cancer patients.Jhalak D Dholakia, Lingling Wang, Isabella Blair, Courtney P Williams, Maria Pisu, Margaret I Liang, Grace M Lee, Tavonna D Kako, Rebecca C Arend, Warner K Huh, Gabrie...> ;Gynecologic Oncology. 2024 Mar 21
- A spatial proteomic study of platinum refractory HGSOC implicates dual AKT and WNT activity linked to an immunosuppressive tumor microenvironment.Scalise, C., Thigpen, H., Moore, J., Dover, B., Norian, L., Meza-Perez, S., Randall, T., Kincaid, K., Birrer, M., Odunsi, K., Arend, R.> ;Gynecologic Oncology. 2024 Feb 19
- Glycosaminoglycan modifications of betaglycan regulate ectodomain shedding to fine-tune TGF-β signaling responses in ovarian cancer.Alex S Choi, Laura M Jenkins-Lane, Wade Barton, Asha Kumari, Carly Lancaster, Calen Raulerson, Hao Ji, Diego Altomare, Mark D Starr, Regina Whitaker, Rebecca Phaeton, ...> ;Cell Communication and Signaling. 2024 Feb 15
- Join now to see all
Press Mentions
Immunotherapy’s Role in Treating Endometrial Cancer Expected to GrowApril 12th, 2023- Two “Homerun” Trials Expected to Change Standard for Advanced, Recurrent Endometrial CancerMarch 28th, 2023
- The Drug Zejula Shows Important Long-Term, Progression-Free Survival Benefit for Patients with Advanced Ovarian CancerOctober 13th, 2022
- Join now to see all
Hospital Affiliations
University of Alabama HospitalBirmingham, Alabama
USA Health University HospitalMobile, Alabama
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
